Tvardi Therapeutics, Inc. (TVRD)
4.28
+0.10
(+2.39%)
USD |
NASDAQ |
Dec 09, 16:00
4.28
0.00 (0.00%)
After-Hours: 18:16
Tvardi Therapeutics Market Cap: 40.15M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 54.85B |
| Novavax, Inc. | 1.084B |
| Precigen, Inc. | 1.245B |
| Xencor, Inc. | 1.199B |
| Denali Therapeutics, Inc. | 2.883B |
Market Cap Related Metrics
| PS Ratio | 5.552 |
| Price to Book Value | 1.441 |
| Price | 4.28 |
| Earnings Yield | -230.2% |